Cesca Therapeutics, Inc.
(NASDAQ : KOOL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.16%97.340.6%$576.84m
ABTAbbott Laboratories
-0.23%82.030.8%$391.85m
TMOThermo Fisher Scientific Inc.
0.06%285.431.0%$387.87m
ISRGIntuitive Surgical, Inc.
1.40%503.512.4%$377.44m
BSXBoston Scientific Corporation
0.32%40.551.1%$319.81m
BDXBecton, Dickinson and Company
0.21%234.641.1%$311.18m
ALGNAlign Technology, Inc.
-5.53%288.796.3%$251.13m
EWEdwards Lifesciences Corporation
0.41%184.691.2%$213.34m
SYKStryker Corporation
0.07%195.601.3%$198.07m
DXCMDexCom, Inc.
0.94%149.438.3%$193.62m
BAXBaxter International Inc.
0.67%78.451.7%$174.51m
ABMDABIOMED, Inc.
0.69%252.703.3%$173.44m
ZBHZimmer Biomet Holdings, Inc.
-0.42%116.961.7%$119.24m
WATWaters Corporation
0.40%204.013.8%$112.87m
IDXXIDEXX Laboratories, Inc.
-0.64%266.043.7%$101.92m

Company Profile

Cesca Therapeutics, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice, clinical grade cell-banking, cell-processing and cell-based therapeutics. The Clinical Development segment develops autologous stem cell-based therapeutics that address significant unmet medical needs for the vascular, cardiology, and orthopedic markets. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.